James M Kaiser

Title: Innovations of James M Kaiser in Bioconjugation Technology

Introduction

James M Kaiser is an accomplished inventor based in Harrisburg, PA (US). He has made significant contributions to the field of bioconjugation, particularly in the development of nanoparticles for targeted drug delivery. His innovative work aims to enhance the efficacy of chemotherapy and imaging agents while minimizing systemic exposure.

Latest Patents

James M Kaiser holds a patent for the invention titled "Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo." This patent describes non-aggregating resorbable calcium phosphosilicate nanoparticles (CPNPs) that are bioconjugated to targeting molecules specific for particular cells. The CPNPs are designed to be stable at normal physiological pH, allowing for the compartmentalization of chemotherapy and imaging agents within the nanoparticles. Once taken up by the target cells, the CPNPs dissolve at intracellular pH, releasing the agents for effective treatment or imaging. This method not only limits systemic exposure but also delivers a higher concentration of the agents directly to the cells.

Career Highlights

James M Kaiser is associated with the Penn State Research Foundation, where he continues to advance his research in bioconjugation technology. His work has the potential to revolutionize the way cancer treatments are administered, providing more targeted and effective therapies.

Collaborations

Throughout his career, James has collaborated with notable colleagues, including Thomas T Morgan and Brian M Barth. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

James M Kaiser is a pioneering inventor whose work in bioconjugation technology is paving the way for more effective cancer treatments. His patented innovations demonstrate a commitment to improving patient outcomes through targeted drug delivery systems.